Capacity-Driven Margin Recovery Play EPACK's +19.4% capacity expansion offers significant upside potential. Near-term margin pressure (100-150 bps) expected during ramp-up phase, with EBITDA growth lagging sales growth initially. However, normalized operations (6-12 months) should drive substantial margin expansion as utilization exceeds 75-80%. IPO funding eliminates debt burden, mitigating financial risk. Critical success factors: demand absorption and execution timelines. Year 2 EBITDA growth of 18-22% projected versus 8-12% sales growth reflects operating leverage. Competitive positioning strengthens with increased production capacity in growing sector, supporting medium-term valuation multiples if execution aligns with guidance.

Capacity-Driven Margin Recovery Play EPACK's +19.4% capacity expansion offers significant upside potential. Near-term margin pressure (100-150 bps) expected during ramp-up phase, with EBITDA growth lagging sales growth initially. However, normalized operations (6-12 months) should drive substantial margin expansion as utilization exceeds 75-80%. IPO funding eliminates debt burden, mitigating financial risk. Critical success factors: demand absorption and execution timelines. Year 2 EBITDA growth of 18-22% projected versus 8-12% sales growth reflects operating leverage. Competitive positioning strengthens with increased production capacity in growing sector, supporting medium-term valuation multiples if execution aligns with guidance.

Capacity-Driven Margin Recovery Play EPACK's +19.4% capacity expansion offers significant upside potential. Near-term margin pressure (100-150 bps) expected during ramp-up phase, with EBITDA growth lagging sales growth initially. However, normalized operations (6-12 months) should drive substantial margin expansion as utilization exceeds 75-80%. IPO funding eliminates debt burden, mitigating financial risk. Critical success factors: demand absorption and execution timelines. Year 2 EBITDA growth of 18-22% projected versus 8-12% sales growth reflects operating leverage. Competitive positioning strengthens with increased production capacity in growing sector, supporting medium-term valuation multiples if execution aligns with guidance.

Capacity-Driven Margin Recovery Play EPACK's +19.4% capacity expansion offers significant upside potential. Near-term margin pressure (100-150 bps) expected during ramp-up phase, with EBITDA growth lagging sales growth initially. However, normalized operations (6-12 months) should drive substantial margin expansion as utilization exceeds 75-80%. IPO funding eliminates debt burden, mitigating financial risk. Critical success factors: demand absorption and execution timelines. Year 2 EBITDA growth of 18-22% projected versus 8-12% sales growth reflects operating leverage. Competitive positioning strengthens with increased production capacity in growing sector, supporting medium-term valuation multiples if execution aligns with guidance.